News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
709,788 Results
Type
Article (43512)
Company Profile (300)
Press Release (665976)
Section
Business (212813)
Career Advice (2137)
Deals (36855)
Drug Delivery (91)
Drug Development (83430)
Employer Resources (174)
FDA (16550)
Job Trends (15492)
News (359068)
Policy (34214)
Tag
Academia (2650)
Africa (808)
Alliances (51557)
Alzheimer's disease (1179)
Approvals (16471)
Arizona (184)
Artificial intelligence (80)
Asia (40737)
Australia (6555)
Bankruptcy (361)
Best Places to Work (11536)
Biosimilars (67)
Biotechnology (193)
C2C Services and Suppliers (81250)
California (1920)
Canada (946)
Cancer (520)
Career advice (1789)
Cell therapy (128)
China (154)
Clinical research (65357)
Collaboration (145)
Colorado (81)
Compensation (83)
Connecticut (78)
COVID-19 (2579)
Cystic fibrosis (75)
Data (323)
Diabetes (86)
Diagnostics (6141)
Drug pricing (74)
Earnings (86729)
Employer resources (148)
Europe (87350)
Events (112727)
Executive appointments (162)
FDA (16785)
Florida (269)
Funding (152)
Gene therapy (103)
GLP-1 (551)
Government (4480)
Healthcare (19071)
Hotbed/Location (494660)
Illinois (266)
Indiana (155)
Infectious disease (2608)
Inflammatory bowel disease (97)
Interviews (326)
IPO (16628)
Job creations (4095)
Job search strategy (1545)
Kansas (95)
Layoffs (417)
Legal (8390)
Lung cancer (119)
Manufacturing (96)
Maryland (410)
Massachusetts (1576)
Medical device (13353)
Medtech (13358)
Mergers & acquisitions (20095)
Metabolic disorders (268)
Michigan (128)
Minnesota (216)
Neuroscience (1335)
New Jersey (600)
New York (604)
NextGen Class of 2024 (6698)
Non-profit (4602)
North Carolina (632)
Northern California (833)
Obesity (161)
Ohio (106)
Opinion (198)
Patents (78)
Pennsylvania (589)
People (58621)
Pharmaceutical (87)
Phase I (20159)
Phase II (28737)
Phase III (21605)
Pipeline (114)
Postmarket research (2705)
Preclinical (8613)
Press Release (68)
Radiopharmaceuticals (236)
Rare diseases (137)
Real estate (6331)
Regulatory (22308)
Research institute (2410)
Resumes & cover letters (362)
South America (1186)
Southern California (778)
Startups (3748)
Texas (248)
United States (8824)
Vaccines (498)
Washington State (257)
Weight loss (145)
Date
Today (78)
Last 7 days (615)
Last 30 days (2470)
Last 365 days (37856)
2024 (26853)
2023 (40923)
2022 (52170)
2021 (56776)
2020 (55318)
2019 (48100)
2018 (36332)
2017 (33646)
2016 (33269)
2015 (39304)
2014 (33151)
2013 (28212)
2012 (30381)
2011 (31067)
2010 (29124)
709,788 Results for "pharmaceutics international inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Bexion Pharmaceuticals, Inc. to Present at BIO International Convention 2024
Bexion Pharmaceuticals, Inc. announced that the Company will present at the 2024 Biotechnology Innovation Organization International Convention taking place June 3-6, 2024, in San Diego, California.
May 31, 2024
·
2 min read
Pharm Country
Virpax® Pharmaceuticals to Present at 2024 BIO International Convention
Virpax ® Pharmaceuticals, Inc. today announced that it will be presenting at the upcoming Bio International Convention in San Diego on Monday, June 3rd at 4:00 p.m. PT. Gerald W. Bruce, CEO of Virpax, will deliver the corporate presentation.
May 29, 2024
·
2 min read
BioCapital
Quoin Pharmaceuticals Announces International Expansion of Ongoing Clinical Trials for Netherton Syndrome
Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage specialty pharmaceutical company focused on rare and orphan diseases, today announces that it will expand its ongoing Netherton Syndrome clinical studies to include international sites.
June 27, 2024
·
4 min read
Pharm Country
Azitra, Inc. Announces Presentation at the 2024 BIO International Convention
Azitra, Inc. today announced that management will present at the 2024 BIO International Convention being held June 3-6, 2024 in San Diego, California.
May 31, 2024
·
4 min read
Business
Dyadic International, Inc. and Proliant Health and Biologicals announce Recombinant Albumin Development and Commercialization Partnership
Dyadic International, Inc. (“Dyadic”) (NASDAQ: DYAI), announced today that they have entered into a development and commercialization partnership with Proliant Health and Biologicals (PHB), a leading supplier of purified proteins for the diagnostic, nutrition and cell culture markets.
June 28, 2024
·
4 min read
Press Releases
Verrica Pharmaceuticals Announces Litigation Settlement with Dormer Laboratories, Inc.
Verrica Pharmaceuticals Inc. today announced the settlement of litigation with Dormer Laboratories, Inc. (“Dormer Labs”).
July 1, 2024
·
5 min read
Biotech Beach
Acadia Pharmaceuticals Presents DAYBUE™ (trofinetide) Real-World Evidence and Additional Data in Rett Syndrome at the 2024 International Rett Syndrome Foundation (IRSF) Annual Scientific Meeting
Acadia Pharmaceuticals, Inc. (Nasdaq: ACAD) today announced that interim data from the open-label real-world LOTUS™ study will be presented at the 2024 International Rett Syndrome Foundation (IRSF) Annual Scientific Meeting, being held this week in Westminster, Colorado.
June 18, 2024
·
10 min read
Business
International Isotopes Inc. Announces Fiscal Results for Fiscal Year 2023
International Isotopes Inc. announces its financial results for the twelve-month periods ended December 31, 2023.
April 1, 2024
·
6 min read
Eupraxia Pharmaceuticals Announces Upcoming Presentations at the Osteoarthritis Research Society International World Congress 2024
Eupraxia Pharmaceuticals Inc. announced that the Company will present two abstracts at the upcoming Osteoarthritis Research Society International World Congress 2024.
April 11, 2024
·
7 min read
Impact Fusion International Inc. Announces the Commencement of a Research Project with Southern University Agricultural and Research Center (SUARC)
Impact Fusion International Inc. (OTC Pink: IFUS) The Company is pleased to announce that a research project with the Southern University Agricultural and Research Center (SUARC) has begun.
May 13, 2024
·
4 min read
1 of 70,979
Next
